96 related articles for article (PubMed ID: 25658637)
1. Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.
Isobe A; Sawada K; Kinose Y; Ohyagi-Hara C; Nakatsuka E; Makino H; Ogura T; Mizuno T; Suzuki N; Morii E; Nakamura K; Sawada I; Toda A; Hashimoto K; Mabuchi S; Ohta T; Morishige K; Kurachi H; Kimura T
PLoS One; 2015; 10(2):e0118080. PubMed ID: 25658637
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1/2 activation.
Lee J; Han Y; Kim S; Jo H; Wang W; Cho U; Kim SI; Kim B; Song YS
Cancer Sci; 2024 May; 115(5):1536-1550. PubMed ID: 38433313
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab Exerts Anti-Tumor Effects on Colorectal Carcinoma Cell Xenografts Corresponding to Expression Levels of Interleukin-6 Receptor.
Chung YC; Chen SJ; Huang CC; Liu WC; Lai MT; Kao TY; Yang WS; Yang CH; Hsu CP; Chang JF
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256960
[TBL] [Abstract][Full Text] [Related]
4. Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.
Groza Y; Lacina L; Kuchař M; Rašková Kafková L; Zachová K; Janoušková O; Osička R; Černý J; Petroková H; Mierzwicka JM; Panova N; Kosztyu P; Sloupenská K; Malý J; Škarda J; Raška M; Smetana K; Malý P
Cell Commun Signal; 2024 May; 22(1):261. PubMed ID: 38715108
[TBL] [Abstract][Full Text] [Related]
5. Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience.
Epis O; Casu C; Belloli L; Schito E; Filippini D; Muscarà M; Bruschi E
Rheumatol Int; 2015 Sep; 35(9):1569-70. PubMed ID: 25773656
[No Abstract] [Full Text] [Related]
6. Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study.
Balsa A; Tovar Beltrán JV; Cáliz Cáliz R; Mateo Bernardo I; García-Vicuña R; Rodríguez-Gómez M; Belmonte Serrano MA; Marras C; Loza Cortina E; Pérez-Pampin E; Vila V
Rheumatol Int; 2015 Sep; 35(9):1525-34. PubMed ID: 25773655
[TBL] [Abstract][Full Text] [Related]
7. Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab.
Wright HL; Mewar D; Bucknall RC; Edwards SW; Moots RJ
Rheumatology (Oxford); 2015 Apr; 54(4):743-4. PubMed ID: 25667432
[No Abstract] [Full Text] [Related]
8. Biological Therapies: Effects of Proinflammatory Pathways and their Inhibition on the Myocardium of Rheumatoid Athritis Patients.
Obermair F; Pieringer H
Curr Med Chem; 2015; 22(16):1911-29. PubMed ID: 25666787
[TBL] [Abstract][Full Text] [Related]
9. Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma.
Stanam A; Love-Homan L; Joseph TS; Espinosa-Cotton M; Simons AL
Mol Oncol; 2015 Aug; 9(7):1371-83. PubMed ID: 25888065
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production.
Chavele KM; Merry E; Ehrenstein MR
J Immunol; 2015 Mar; 194(6):2482-5. PubMed ID: 25681343
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.
Milagre CS; Gopinathan G; Everitt G; Thompson RG; Kulbe H; Zhong H; Hollingsworth RE; Grose R; Bowtell DD; Hochhauser D; Balkwill FR
Cancer Res; 2015 Apr; 75(7):1255-64. PubMed ID: 25670170
[TBL] [Abstract][Full Text] [Related]
12. Can Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis?
Benucci M; Meacci F; Manfredi M; Gobbi FL; Infantino M; Ricci C; Sarzi-Puttini P; Atzeni F
Curr Rheumatol Rev; 2015 Feb; ():. PubMed ID: 25666883
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
Loricera J; Blanco R; Hernández JL; Castañeda S; Mera A; Pérez-Pampín E; Peiró E; Humbría A; Calvo-Alén J; Aurrecoechea E; Narváez J; Sánchez-Andrade A; Vela P; Díez E; Mata C; Lluch P; Moll C; Hernández Í; Calvo-Río V; Ortiz-Sanjuán F; González-Vela C; Pina T; González-Gay MÁ
Semin Arthritis Rheum; 2015 Jun; 44(6):717-23. PubMed ID: 25697557
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
Galvão VR; Castells MC
J Allergy Clin Immunol Pract; 2015; 3(2):175-85; quiz 186. PubMed ID: 25754718
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid- and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
Sakai R; Shibata A; Chino K; Kondo T; Okuyama A; Takei H; Amano K
Mod Rheumatol; 2015 Sep; 25(5):810-1. PubMed ID: 25736354
[No Abstract] [Full Text] [Related]
16. Intracisternal administration of an interleukin-6 receptor antagonist attenuates surgery-induced cognitive impairment by inhibition of neuroinflammatory responses in aged rats.
Jiang P; Ling Q; Liu H; Tu W
Exp Ther Med; 2015 Mar; 9(3):982-986. PubMed ID: 25667664
[TBL] [Abstract][Full Text] [Related]
17. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition.
Garbers C; Aparicio-Siegmund S; Rose-John S
Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.
Weiner-Gorzel K; Dempsey E; Milewska M; McGoldrick A; Toh V; Walsh A; Lindsay S; Gubbins L; Cannon A; Sharpe D; O'Sullivan J; Murphy M; Madden SF; Kell M; McCann A; Furlong F
Cancer Med; 2015 May; 4(5):745-58. PubMed ID: 25684390
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells.
Minichsdorfer C; Wasinger C; Sieczkowski E; Atil B; Hohenegger M
Melanoma Res; 2015 Aug; 25(4):284-94. PubMed ID: 26020489
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
